apalutamide and the titan clinical trial
Published 5 years ago • 1.2K plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
1:28
apalutamide plus adt leads to survival benefit in mcspc
-
3:06
titan trial
-
6:42
titan trial
-
31:13
titan trial | investigating the addition of apalutamide to androgen deprivation therapy
-
1:15
dr. agarwal on impact of the titan trial with apalutamide plus adt in mcspc
-
1:50
dr. agarwal on pfs2 data from the titan trial in mcspc
-
4:23
apalutamide for high-risk prostate cancer | learn about clinical trials
-
17:59
what is oligometastatic prostate cancer?
-
12:08
new fda approval: darolutamide for hormone-sensitive disease | mark scholz, md | pcri
-
4:12
anthracycline
-
0:54
apalutamide combination is well tolerated in metastatic castration-sensitive prostate cancer
-
6:52
apalutamide: understanding its mechanism of action
-
2:50
live from asco: apalutamide for castration-sensitive prostate cancer
-
3:11
erleada or apalutamide adt treatment
-
5:20
apalutamide, darolutamide and enzalutamide for nonmetastatic castration-resistant prostate cancer.
-
8:33
titan phase 3 trial with apalutamide in metastatic castration sensitive prostate cancer
-
0:57
dr. agarwal on the tolerability of apalutamide in mcspc
-
2:29
update: fda approves apalutamide (erleada) for metastatic castration-sensitive prostate cancer
-
1:23
dr. saad on the safety profile of apalutamide in m0crpc
-
1:34
dr. chi on the titan trial results in metastatic castration-sensitive prostate cancer
-
4:36
nonmetastatic crpc: considerations for apalutamide
-
0:36
how is #apalutamide standard treatment beneficial to patients with node-positive prostate cancer?